Digital Microfluidics (DMF) has emerged as a disruptive methodology for the control and manipulation of low volume droplets. In DMF, each droplet acts as a single reactor, which allows for extensive multiparallelization of biological and chemical reactions at a much smaller scale. DMF devices open entirely new and promising pathways for multiplex analysis and reaction occurring in a miniaturized format, thus allowing for healthcare decentralization from major laboratories to point-of-care with accurate, robust and inexpensive molecular diagnostics. Here, we shall focus on DMF platforms specifically designed for nucleic acid amplification, which is key for molecular diagnostics of several diseases and conditions, from pathogen identification to cancer mutations detection. Particular attention will be given to the device architecture, materials and nucleic acid amplification applications in validated settings.

Original languageEnglish
Article number1495
Issue number7
Publication statusPublished - 1 Jul 2017


  • Digital microfluidics
  • Nucleic acid amplification
  • Point-of-care diagnostics


Dive into the research topics of 'Digital microfluidics for nucleic acid amplification'. Together they form a unique fingerprint.

Cite this